Evidence map›Paper›PMID 37954511›Full record

ArticleVirus evolution2022

Phylogeographic analysis of Tula hantavirus highlights a single introduction to central Europe.

Valentina Cirkovic, Simon Dellicour, Gorana Stamenkovic, Marina Siljic, Ana Gligic, Maja Stanojevic

Open access · goldAbstract read
In one paragraph

Article in Virus evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Valentina CirkovicFaculty of Medicine, University of Belgrade, Dr Subotica 8, Belgrade 11000, Serbia.
Simon DellicourSpatial Epidemiology Lab (SpELL), Université Libre de Bruxelles, CP160/13, 50, av. FD Roosevelt, Bruxelles 1050, Belgium.ORCID https://orcid.org/0000-0001-9558-1052
Gorana StamenkovicUniversity of Belgrade, Institute for Biological Research 'Siniša Stanković', Bulevar despota Stefana 142, Belgrade 11108, Serbia.
Marina SiljicFaculty of Medicine, University of Belgrade, Dr Subotica 8, Belgrade 11000, Serbia.
Ana GligicInstitute of Virology, Vaccines and Sera Torlak, Vojvode Stepe 458, Belgrade 11000, Serbia.
Maja StanojevicFaculty of Medicine, University of Belgrade, Dr Subotica 8, Belgrade 11000, Serbia.ORCID https://orcid.org/0000-0002-4643-4272
University of Belgrade · RSInstitute of Virology, Vaccines and Sera “Torlak” · RSUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orthohantaviruses are zoonotic pathogens of humans, unique among the bunyaviruses in not being transmitted by an arthropod vector. Tula orthohantavirus (TULV) is an old-world hantavirus, of yet unclear human pathogenicity, with few reported cases of clinically relevant human infection. So far, phylogeographic studies exploring the global pathways of hantaviral migration are scarce and generally do not focus on a specific hantavirus species. The aim of the present study was to reconstruct the dispersal history of TULV lineages across Eurasia based on S segment sequences sampled from different geographic areas. Maximum-likelihood and Bayesian inference methods were used to perform the phylogenetic analysis and phylogeographic reconstructions. Sampling time and trapping localities were obtained for a total of 735 TULV S segment sequences available in public databases at the time of the study. The estimated substitution rate of the analyzed partial S segment alignment was 2.26 × 10

Indexed as

EurasiaHantaviridaephylogeographyTula hantavirus

Identifiers

PMID37954511
PMCPMC10634634
OpenAlexW4312077101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.